Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia

Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R , expressed at physiological lev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications Jg. 12; H. 1; S. 7268 - 16
Hauptverfasser: Almeida, Afonso R. M., Neto, João L., Cachucho, Ana, Euzébio, Mayara, Meng, Xiangyu, Kim, Rathana, Fernandes, Marta B., Raposo, Beatriz, Oliveira, Mariana L., Ribeiro, Daniel, Fragoso, Rita, Zenatti, Priscila P., Soares, Tiago, de Matos, Mafalda R., Corrêa, Juliana Ronchi, Duque, Mafalda, Roberts, Kathryn G., Gu, Zhaohui, Qu, Chunxu, Pereira, Clara, Pyne, Susan, Pyne, Nigel J., Barreto, Vasco M., Bernard-Pierrot, Isabelle, Clappier, Emannuelle, Mullighan, Charles G., Grosso, Ana R., Yunes, J. Andrés, Barata, João T.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 14.12.2021
Nature Publishing Group
Nature Portfolio
Schlagworte:
1-Phosphatidylinositol 3-kinase
13/31
13/95
38
38/77
38/91
42/44
45
631/67/1990/283/2125
631/67/395
631/67/70
64/110
692/4017
692/4028/67/1990/283/2125
82/58
Acute lymphoblastic leukemia
Animal models
Animals
Antineoplastic Agents - pharmacology
Cell Line, Tumor
Cell Survival - genetics
Cell viability
Cytokines
Gain of Function Mutation
Heterozygote
Homozygote
Humanities and Social Sciences
Humans
Interleukin 7
Interleukin 7 receptors
Interleukin-7 Receptor alpha Subunit - genetics
Interleukin-7 Receptor alpha Subunit - metabolism
Kinases
Leukemia
Leukemogenesis
Life Sciences
Lymphatic leukemia
Lymphocytes B
Malignancy
Mice
multidisciplinary
Mutants
Mutation
Myc protein
Pax5 protein
Penetrance
Precancerous Conditions - genetics
Precancerous Conditions - pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Precursor Cells, B-Lymphoid - pathology
Precursors
Proto-Oncogene Proteins p21(ras) - genetics
Receptors
Science
Science (multidisciplinary)
Signal Transduction - drug effects
Signaling
Stat5 protein
Subgroups
Suppressors
TOR protein
Transcription
Tumors
ISSN:2041-1723, 2041-1723
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R , expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2 , downregulation of tumor suppressors such as Ikzf1 or Arid2 , and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy. Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a knock-in murine model to show that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukaemia.
AbstractList Interleukin-7 receptor α (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2, downregulation of tumor suppressors such as Ikzf1 or Arid2, and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy.
Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R , expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2 , downregulation of tumor suppressors such as Ikzf1 or Arid2 , and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy. Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a knock-in murine model to show that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukaemia.
Interleukin-7 receptor α (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2, downregulation of tumor suppressors such as Ikzf1 or Arid2, and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy. Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a knock-in murine model to show that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukaemia.
Abstract Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R , expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2 , downregulation of tumor suppressors such as Ikzf1 or Arid2 , and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy.
Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a knock-in murine model to show that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukaemia.
Interleukin-7 receptor α (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2, downregulation of tumor suppressors such as Ikzf1 or Arid2, and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy.Interleukin-7 receptor α (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2, downregulation of tumor suppressors such as Ikzf1 or Arid2, and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy.
Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R , expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2 , downregulation of tumor suppressors such as Ikzf1 or Arid2 , and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy.
ArticleNumber 7268
Author Ribeiro, Daniel
Raposo, Beatriz
Neto, João L.
Oliveira, Mariana L.
Qu, Chunxu
Roberts, Kathryn G.
Almeida, Afonso R. M.
Meng, Xiangyu
de Matos, Mafalda R.
Barreto, Vasco M.
Bernard-Pierrot, Isabelle
Duque, Mafalda
Fernandes, Marta B.
Yunes, J. Andrés
Euzébio, Mayara
Zenatti, Priscila P.
Mullighan, Charles G.
Cachucho, Ana
Pyne, Nigel J.
Gu, Zhaohui
Soares, Tiago
Pyne, Susan
Grosso, Ana R.
Kim, Rathana
Clappier, Emannuelle
Pereira, Clara
Barata, João T.
Fragoso, Rita
Corrêa, Juliana Ronchi
Author_xml – sequence: 1
  givenname: Afonso R. M.
  surname: Almeida
  fullname: Almeida, Afonso R. M.
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 2
  givenname: João L.
  orcidid: 0000-0003-0863-158X
  surname: Neto
  fullname: Neto, João L.
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 3
  givenname: Ana
  surname: Cachucho
  fullname: Cachucho, Ana
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 4
  givenname: Mayara
  surname: Euzébio
  fullname: Euzébio, Mayara
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Centro Infantil Boldrini
– sequence: 5
  givenname: Xiangyu
  surname: Meng
  fullname: Meng, Xiangyu
  organization: Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer
– sequence: 6
  givenname: Rathana
  orcidid: 0000-0002-9987-7237
  surname: Kim
  fullname: Kim, Rathana
  organization: Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212
– sequence: 7
  givenname: Marta B.
  orcidid: 0000-0002-0627-4534
  surname: Fernandes
  fullname: Fernandes, Marta B.
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 8
  givenname: Beatriz
  surname: Raposo
  fullname: Raposo, Beatriz
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 9
  givenname: Mariana L.
  surname: Oliveira
  fullname: Oliveira, Mariana L.
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 10
  givenname: Daniel
  surname: Ribeiro
  fullname: Ribeiro, Daniel
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 11
  givenname: Rita
  orcidid: 0000-0002-9206-1964
  surname: Fragoso
  fullname: Fragoso, Rita
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 12
  givenname: Priscila P.
  surname: Zenatti
  fullname: Zenatti, Priscila P.
  organization: Centro Infantil Boldrini
– sequence: 13
  givenname: Tiago
  surname: Soares
  fullname: Soares, Tiago
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 14
  givenname: Mafalda R.
  surname: de Matos
  fullname: de Matos, Mafalda R.
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 15
  givenname: Juliana Ronchi
  orcidid: 0000-0003-1502-0293
  surname: Corrêa
  fullname: Corrêa, Juliana Ronchi
  organization: Centro Infantil Boldrini
– sequence: 16
  givenname: Mafalda
  orcidid: 0000-0002-1459-161X
  surname: Duque
  fullname: Duque, Mafalda
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
– sequence: 17
  givenname: Kathryn G.
  orcidid: 0000-0001-7626-4043
  surname: Roberts
  fullname: Roberts, Kathryn G.
  organization: Department of Pathology and Hematological Malignancies Program, St. Jude Children’s Research Hospital
– sequence: 18
  givenname: Zhaohui
  surname: Gu
  fullname: Gu, Zhaohui
  organization: Department of Pathology and Hematological Malignancies Program, St. Jude Children’s Research Hospital
– sequence: 19
  givenname: Chunxu
  surname: Qu
  fullname: Qu, Chunxu
  organization: Department of Pathology and Hematological Malignancies Program, St. Jude Children’s Research Hospital
– sequence: 20
  givenname: Clara
  surname: Pereira
  fullname: Pereira, Clara
  organization: Smurfit Institute of Genetics, Trinity College Dublin, University of Dublin
– sequence: 21
  givenname: Susan
  orcidid: 0000-0002-6608-9584
  surname: Pyne
  fullname: Pyne, Susan
  organization: Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde
– sequence: 22
  givenname: Nigel J.
  surname: Pyne
  fullname: Pyne, Nigel J.
  organization: Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde
– sequence: 23
  givenname: Vasco M.
  surname: Barreto
  fullname: Barreto, Vasco M.
  organization: DNA Breaks Laboratory, CEDOC - Chronic Diseases Research Center, NOVA Medical School - Faculdade de Ciências Médicas, Universidade NOVA de Lisboa
– sequence: 24
  givenname: Isabelle
  orcidid: 0000-0002-8967-5092
  surname: Bernard-Pierrot
  fullname: Bernard-Pierrot, Isabelle
  organization: Institut Curie, PSL Research University, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer
– sequence: 25
  givenname: Emannuelle
  surname: Clappier
  fullname: Clappier, Emannuelle
  organization: Hematology Laboratory, Saint-Louis Hospital, AP-HP, Paris, France, and Saint-Louis Research Institute, Université de Paris, INSERM U944/Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 7212
– sequence: 26
  givenname: Charles G.
  orcidid: 0000-0002-1871-1850
  surname: Mullighan
  fullname: Mullighan, Charles G.
  organization: Department of Pathology and Hematological Malignancies Program, St. Jude Children’s Research Hospital
– sequence: 27
  givenname: Ana R.
  orcidid: 0000-0001-6974-4209
  surname: Grosso
  fullname: Grosso, Ana R.
  organization: UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa
– sequence: 28
  givenname: J. Andrés
  orcidid: 0000-0002-1316-3525
  surname: Yunes
  fullname: Yunes, J. Andrés
  email: andres@boldrini.org.br
  organization: Centro Infantil Boldrini
– sequence: 29
  givenname: João T.
  orcidid: 0000-0002-4826-8976
  surname: Barata
  fullname: Barata, João T.
  email: joao_barata@medicina.ulisboa.pt
  organization: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34907175$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03854013$$DView record in HAL
BookMark eNp9ks1u1DAUhSNUREvpC7BAkdjAIuC_-GeD1FZARxqJDawtx3FmPCR2sJ2R-li8CM-EM2mhnUUjRXFuvnN8nXNfFifOO1MUryH4AAHmHyOBhLIKIFghBgWr6mfFGQIEVpAhfPJgfVpcxLgD-cICckJeFKeYCMAgq8-K3colE3oz_bSuYmUw2ozJh_LP73KYkkrWO9WXSie7P7yUWrnSOpusSqYcMz-FmPmrSpt-Bqdc7m-HceubXsVkdTmbm8GqV8XzTvXRXNw9z4sfXz5_v76p1t--rq4v15WmAKSqbTrRKgUJ4R01iNY1QlBAhbjuRMMUYYy0oOFCQNrRmkMkBOtAl2_aQg3webFafFuvdnIMdlDhVnpl5aHgw0aqkBvrjeTY0JYKjAjCBNSU14QhAZlBqiMtY9nr0-I1Ts1gWm1cCqp_ZPr4i7NbufF7ySmDtSDZ4P1isD2S3Vyu5VzLWdYEQLyHmX13t1nwvyYTkxxsnH-rcsZPUSIKc6Zzpxl9e4Tu_BRyVDMFBKc4nyhTbx52_2__-_gzwBdABx9jMJ3Udgk9H8b2EgI5D5tchk3mYZOHYZOzFB1J792fFOFFFDPsNib8b_sJ1V99aeXC
CitedBy_id crossref_primary_10_1080_2162402X_2024_2371575
crossref_primary_10_3389_fimmu_2023_1285743
crossref_primary_10_1016_j_imlet_2023_07_004
crossref_primary_10_1111_bjh_19467
crossref_primary_10_3389_fonc_2022_1032336
crossref_primary_10_3390_ijms25126589
crossref_primary_10_1007_s11864_022_00963_3
crossref_primary_10_1089_hum_2024_103
crossref_primary_10_1084_jem_20221080
crossref_primary_10_3390_ijms23147562
crossref_primary_10_1002_eji_202250093
crossref_primary_10_3390_ijms241813937
crossref_primary_10_1111_bjh_20057
crossref_primary_10_1186_s12943_022_01516_w
crossref_primary_10_4049_jimmunol_2200635
crossref_primary_10_1016_j_gene_2024_148131
crossref_primary_10_1016_j_heliyon_2023_e18836
crossref_primary_10_1016_j_ijbiomac_2025_144201
crossref_primary_10_1093_jleuko_qiae015
crossref_primary_10_1186_s12967_025_06402_9
crossref_primary_10_1515_hsz_2023_0344
crossref_primary_10_1038_s41419_023_06019_0
crossref_primary_10_1080_17474086_2025_2528886
crossref_primary_10_1182_blood_2023021088
crossref_primary_10_3390_ijms26147003
crossref_primary_10_1038_s41467_022_28218_7
crossref_primary_10_1111_jcmm_17904
crossref_primary_10_3390_diseases13070206
crossref_primary_10_3389_fimmu_2023_1146628
crossref_primary_10_1016_j_jbior_2022_100940
crossref_primary_10_1038_s41598_025_87684_3
crossref_primary_10_1038_s41375_022_01590_5
crossref_primary_10_1182_blood_2023019721
crossref_primary_10_1182_blood_2022017819
crossref_primary_10_1016_j_micpath_2024_107252
crossref_primary_10_4049_jimmunol_2300483
crossref_primary_10_1186_s12864_025_11445_9
Cites_doi 10.1073/pnas.2436348100
10.1038/ng.806
10.1016/j.ccr.2010.11.014
10.1186/s13059-018-1578-y
10.1016/S0952-7915(00)00122-9
10.1038/nri3570
10.1084/jem.20040789
10.1073/pnas.0506580102
10.1038/s41375-019-0430-z
10.1182/blood-2012-02-413021
10.1073/pnas.1702489114
10.3324/haematol.2018.204974
10.1073/pnas.1814397115
10.1038/nbt.1754
10.4161/fly.19695
10.1038/leu.2011.56
10.1093/nar/gkv007
10.1182/blood-2016-12-758979
10.1038/s41375-017-0001-0
10.1002/immu.200310005
10.4049/jimmunol.175.11.7325
10.1186/gb-2006-7-7-r66
10.1182/blood.V98.5.1524
10.1182/blood-2012-04-422352
10.1371/journal.pmed.0050083
10.1016/j.cels.2015.12.004
10.1038/ncomms7471
10.1038/nbt.3519
10.1093/nar/gku1363
10.1038/nmeth.1322
10.1093/bioinformatics/btp616
10.1200/JCO.2016.70.7836
10.1172/JCI81468
10.1038/ni.2136
10.1158/0008-5472.CAN-13-2732
10.1172/JCI81158
10.1084/jem.20131735
10.1073/pnas.1400958111
10.1073/pnas.192445899
10.1084/jem.20101947
10.1182/blood-2016-05-707653
10.1021/acs.jmedchem.9b00162
10.1038/s41590-019-0479-x
10.1084/jem.20110580
10.1182/blood-2012-08-451278
10.1016/S0140-6736(12)62187-4
10.1101/gad.6.1.61
10.1074/mcp.M113.037309
10.1084/jem.181.4.1519
10.1093/bioinformatics/btp352
10.1038/nm.4505
10.1182/blood-2009-10-246876
10.1158/2159-8290.CD-15-0892
10.1093/bioinformatics/btq033
10.1038/nmeth.3364
10.1093/bioinformatics/btt203
10.4049/jimmunol.0800489
10.1182/blood-2018-10-882142
10.1182/asheducation-2016.1.561
10.1038/nprot.2009.97
10.1016/j.ccr.2012.06.005
10.1084/jem.20122727
10.1371/journal.pone.0124661
10.1038/nmeth.3901
10.1038/s41588-018-0315-5
10.1016/S1470-2045(08)70339-5
10.1093/bioinformatics/btp324
10.1007/s11248-007-9089-8
10.1038/nature10413
10.1038/ni.3716
10.1182/blood.2019000982
10.1084/jem.180.5.1955
10.1016/j.immuni.2004.07.016
10.1158/0008-5472.CAN-10-3606
10.1038/ng.924
10.1371/journal.pone.0007767
10.1038/bcj.2017.53
10.1056/NEJMoa1403088
10.1182/bloodadvances.2017000547
10.1038/s41375-021-01326-x
10.1182/blood.2019000553
10.1001/jamaoncol.2019.5582
ContentType Journal Article
Copyright The Author(s) 2021
2021. The Author(s).
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: The Author(s) 2021
– notice: 2021. The Author(s).
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
1XC
VOOES
5PM
DOA
DOI 10.1038/s41467-021-27197-5
DatabaseName Springer Nature Link
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Computer Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database ProQuest
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE




MEDLINE - Academic
CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 16
ExternalDocumentID oai_doaj_org_article_83e6d6932423405685472917e2af4d77
PMC8671594
oai:HAL:hal-03854013v1
34907175
10_1038_s41467_021_27197_5
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
  grantid: ERC CoG-648455
  funderid: https://doi.org/10.13039/100010663
– fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
  grantid: NCI Outstanding Investigator Award R35 R35CA197695
  funderid: https://doi.org/10.13039/100000054
– fundername: Ministry of Education and Science | Fundação para a Ciência e a Tecnologia (Portuguese Science and Technology Foundation)
  grantid: CEECIND/02699/2017; FAPESP/20015/2014
  funderid: https://doi.org/10.13039/501100001871
– fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation)
  grantid: 2014/20015-5
  funderid: https://doi.org/10.13039/501100001807
– fundername: NCI NIH HHS
  grantid: R35 CA197695
– fundername: ;
  grantid: ERC CoG-648455
– fundername: ;
  grantid: NCI Outstanding Investigator Award R35 R35CA197695
– fundername: ;
  grantid: CEECIND/02699/2017; FAPESP/20015/2014
– fundername: ;
  grantid: 2014/20015-5
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
SOI
7X8
PUEGO
1XC
4.4
BAPOH
CAG
COF
EJD
LGEZI
LOTEE
NADUK
NXXTH
VOOES
5PM
ID FETCH-LOGICAL-c600t-dbf9daa1448f6e265522191a28cf9b7a4774d0b89916f65812997f0f7f06d1c03
IEDL.DBID DOA
ISICitedReferencesCount 40
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000730391400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2041-1723
IngestDate Fri Oct 03 12:53:14 EDT 2025
Tue Nov 04 02:01:53 EST 2025
Sat Nov 29 14:58:36 EST 2025
Thu Sep 04 18:00:25 EDT 2025
Tue Oct 07 06:56:56 EDT 2025
Mon Jul 21 06:09:31 EDT 2025
Sat Nov 29 06:29:38 EST 2025
Tue Nov 18 21:20:03 EST 2025
Fri Feb 21 02:39:14 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2021. The Author(s).
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-dbf9daa1448f6e265522191a28cf9b7a4774d0b89916f65812997f0f7f06d1c03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4826-8976
0000-0001-7626-4043
0000-0002-1316-3525
0000-0002-8967-5092
0000-0002-9987-7237
0000-0002-1871-1850
0000-0001-6974-4209
0000-0002-0627-4534
0000-0002-6608-9584
0000-0003-0863-158X
0000-0003-1502-0293
0000-0002-9206-1964
0000-0002-1459-161X
OpenAccessLink https://doaj.org/article/83e6d6932423405685472917e2af4d77
PMID 34907175
PQID 2609863423
PQPubID 546298
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_83e6d6932423405685472917e2af4d77
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8671594
hal_primary_oai_HAL_hal_03854013v1
proquest_miscellaneous_2610412340
proquest_journals_2609863423
pubmed_primary_34907175
crossref_citationtrail_10_1038_s41467_021_27197_5
crossref_primary_10_1038_s41467_021_27197_5
springer_journals_10_1038_s41467_021_27197_5
PublicationCentury 2000
PublicationDate 2021-12-14
PublicationDateYYYYMMDD 2021-12-14
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-14
  day: 14
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Roberts (CR15) 2012; 22
Duque-Afonso (CR23) 2015; 125
Jiang (CR68) 2018; 19
Shochat (CR14) 2011; 208
Johnson, Shah, Panoskaltsis-Mortari, LeBien (CR28) 2005; 175
Morrow, Lee, Gillis, Yancopoulos, Alt (CR26) 1992; 6
Rubio-Camarillo, Gomez-Lopez, Fernandez, Valencia, Pisano (CR62) 2013; 29
Inaba, Greaves, Mullighan (CR1) 2013; 381
Passet (CR18) 2019; 133
Den Boer (CR56) 2009; 10
Boutros, Bras, Huber (CR83) 2006; 7
Mandal (CR29) 2011; 12
Barata (CR41) 2004; 200
Henriques, Rino, Nibbs, Graham, Barata (CR49) 2010; 115
Quinlan, Hall (CR75) 2010; 26
Bolotin (CR76) 2015; 12
Li (CR74) 2009; 25
Clark, Mandal, Ochiai, Singh (CR8) 2014; 14
Tran, Loh (CR46) 2016; 2016
Wisniewski, Zougman, Nagaraj, Mann (CR78) 2009; 6
Liberzon (CR82) 2015; 1
Sorich (CR36) 2008; 5
Schnutgen, Ghyselinck (CR60) 2007; 16
Jiang, Oldridge, Diskin, Zhang (CR69) 2015; 43
Robinson, McCarthy, Smyth (CR72) 2010; 26
Ritchie (CR73) 2015; 43
Terwilliger, Abdul-Hay (CR3) 2017; 7
Robinson (CR70) 2011; 29
CR2
Peschon (CR5) 1994; 180
Cheng (CR11) 2016; 126
Roberts (CR58) 2017; 1
Wisniewski, Hein, Cox, Mann (CR79) 2014; 13
Martin-Lorenzo (CR10) 2015; 5
Reshmi (CR33) 2017; 129
Good (CR38) 2018; 24
Meyer (CR37) 2011; 19
Ott (CR32) 2012; 120
CR44
CR43
Bray, Pimentel, Melsted, Pachter (CR71) 2016; 34
Puel, Leonard (CR6) 2000; 12
Antony-Debre (CR54) 2012; 120
Buchner (CR35) 2015; 6
Park (CR48) 2004; 21
Li, Durbin (CR63) 2009; 25
Brown (CR30) 2003; 100
Gu (CR16) 2019; 51
Bastian (CR19) 2019; 33
Katerndahl (CR50) 2017; 18
Li (CR17) 2018; 115
Heizmann, Kastner, Chan (CR57) 2013; 210
von Freeden-Jeffry (CR4) 1995; 181
Silva (CR25) 2011; 71
Durinck, Spellman, Birney, Huber (CR77) 2009; 4
Cramer (CR21) 2018; 32
Zenatti (CR13) 2011; 43
Keane (CR67) 2011; 477
Schwartzman (CR51) 2017; 114
Parrish (CR9) 2009; 182
de Boer (CR61) 2003; 33
Yokoyama (CR22) 2013; 122
Iacobucci, Mullighan (CR34) 2017; 35
DePristo (CR65) 2011; 43
Kharabi Masouleh (CR27) 2014; 111
Homer, Merriman, Nelson (CR64) 2009; 4
Siegemund, Shepherd, Xiao, Sauer (CR24) 2015; 10
Barata, Cardoso, Nadler, Boussiotis (CR40) 2001; 98
Tasian (CR39) 2017; 129
Gonzalez-Garcia (CR52) 2019; 134
Zaliova (CR47) 2019; 104
Cingolani (CR66) 2012; 6
Wallington-Beddoe (CR59) 2014; 74
Subramanian (CR81) 2005; 102
Adams (CR42) 2019; 62
Heltemes-Harris (CR12) 2011; 208
Askew, Ashmun, Simmons, Cleveland (CR53) 1991; 6
Barata, Durum, Seddon (CR7) 2019; 20
Silva (CR31) 2011; 25
Roberts (CR45) 2014; 371
Nishioka (CR55) 2002; 99
Tyanova (CR80) 2016; 13
Treanor (CR20) 2014; 211
VI Brown (27197_CR30) 2003; 100
SE Johnson (27197_CR28) 2005; 175
T Terwilliger (27197_CR3) 2017; 7
JT Barata (27197_CR7) 2019; 20
S Durinck (27197_CR77) 2009; 4
L Bastian (27197_CR19) 2019; 33
M Rubio-Camarillo (27197_CR62) 2013; 29
S Siegemund (27197_CR24) 2015; 10
JH Park (27197_CR48) 2004; 21
KG Roberts (27197_CR58) 2017; 1
B Kharabi Masouleh (27197_CR27) 2014; 111
A Silva (27197_CR31) 2011; 25
U von Freeden-Jeffry (27197_CR4) 1995; 181
M Zaliova (27197_CR47) 2019; 104
K Yokoyama (27197_CR22) 2013; 122
SK Tasian (27197_CR39) 2017; 129
LM Heltemes-Harris (27197_CR12) 2011; 208
JT Barata (27197_CR41) 2004; 200
S Gonzalez-Garcia (27197_CR52) 2019; 134
S Tyanova (27197_CR80) 2016; 13
I Antony-Debre (27197_CR54) 2012; 120
DS Askew (27197_CR53) 1991; 6
J Duque-Afonso (27197_CR23) 2015; 125
P Cingolani (27197_CR66) 2012; 6
B Heizmann (27197_CR57) 2013; 210
H Li (27197_CR74) 2009; 25
CM Henriques (27197_CR49) 2010; 115
JJ Peschon (27197_CR5) 1994; 180
Y Jiang (27197_CR68) 2018; 19
JT Barata (27197_CR40) 2001; 98
PP Zenatti (27197_CR13) 2011; 43
O Schwartzman (27197_CR51) 2017; 114
Z Gu (27197_CR16) 2019; 51
M Mandal (27197_CR29) 2011; 12
SD Cramer (27197_CR21) 2018; 32
27197_CR44
TH Tran (27197_CR46) 2016; 2016
JF Li (27197_CR17) 2018; 115
NL Bray (27197_CR71) 2016; 34
27197_CR43
JT Robinson (27197_CR70) 2011; 29
CDS Katerndahl (27197_CR50) 2017; 18
A Martin-Lorenzo (27197_CR10) 2015; 5
MA Morrow (27197_CR26) 1992; 6
DR Adams (27197_CR42) 2019; 62
A Silva (27197_CR25) 2011; 71
M Boutros (27197_CR83) 2006; 7
ME Ritchie (27197_CR73) 2015; 43
27197_CR2
MJ Sorich (27197_CR36) 2008; 5
I Iacobucci (27197_CR34) 2017; 35
F Schnutgen (27197_CR60) 2007; 16
M Passet (27197_CR18) 2019; 133
N Homer (27197_CR64) 2009; 4
ML Den Boer (27197_CR56) 2009; 10
JR Wisniewski (27197_CR79) 2014; 13
A Puel (27197_CR6) 2000; 12
CT Wallington-Beddoe (27197_CR59) 2014; 74
J de Boer (27197_CR61) 2003; 33
MR Clark (27197_CR8) 2014; 14
Z Good (27197_CR38) 2018; 24
H Inaba (27197_CR1) 2013; 381
KG Roberts (27197_CR45) 2014; 371
JR Wisniewski (27197_CR78) 2009; 6
M Nishioka (27197_CR55) 2002; 99
Y Cheng (27197_CR11) 2016; 126
A Subramanian (27197_CR81) 2005; 102
TM Keane (27197_CR67) 2011; 477
DA Bolotin (27197_CR76) 2015; 12
MD Robinson (27197_CR72) 2010; 26
SC Reshmi (27197_CR33) 2017; 129
KG Roberts (27197_CR15) 2012; 22
C Shochat (27197_CR14) 2011; 208
YK Parrish (27197_CR9) 2009; 182
A Liberzon (27197_CR82) 2015; 1
AR Quinlan (27197_CR75) 2010; 26
LH Meyer (27197_CR37) 2011; 19
CJ Ott (27197_CR32) 2012; 120
H Li (27197_CR63) 2009; 25
MA DePristo (27197_CR65) 2011; 43
M Buchner (27197_CR35) 2015; 6
LM Treanor (27197_CR20) 2014; 211
Y Jiang (27197_CR69) 2015; 43
References_xml – volume: 100
  start-page: 15113
  year: 2003
  end-page: 15118
  ident: CR30
  article-title: Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2436348100
– volume: 43
  start-page: 491
  year: 2011
  end-page: 498
  ident: CR65
  article-title: A framework for variation discovery and genotyping using next-generation DNA sequencing data
  publication-title: Nat. Genet.
  doi: 10.1038/ng.806
– volume: 19
  start-page: 206
  year: 2011
  end-page: 217
  ident: CR37
  article-title: Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.11.014
– volume: 19
  year: 2018
  ident: CR68
  article-title: CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing
  publication-title: Genome Biol.
  doi: 10.1186/s13059-018-1578-y
– volume: 12
  start-page: 468
  year: 2000
  end-page: 473
  ident: CR6
  article-title: Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/S0952-7915(00)00122-9
– volume: 14
  start-page: 69
  year: 2014
  end-page: 80
  ident: CR8
  article-title: Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3570
– volume: 200
  start-page: 659
  year: 2004
  end-page: 669
  ident: CR41
  article-title: Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20040789
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  ident: CR81
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0506580102
– volume: 33
  start-page: 1895
  year: 2019
  end-page: 1909
  ident: CR19
  article-title: PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0430-z
– volume: 120
  start-page: 2843
  year: 2012
  end-page: 2852
  ident: CR32
  article-title: BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2012-02-413021
– volume: 114
  start-page: E4030
  year: 2017
  end-page: E4039
  ident: CR51
  article-title: Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1702489114
– volume: 104
  start-page: 1396
  year: 2019
  end-page: 1406
  ident: CR47
  article-title: Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
  publication-title: Haematologica
  doi: 10.3324/haematol.2018.204974
– volume: 115
  start-page: E11711
  year: 2018
  end-page: E11720
  ident: CR17
  article-title: Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1814397115
– volume: 29
  start-page: 24
  year: 2011
  end-page: 26
  ident: CR70
  article-title: Integrative genomics viewer
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1754
– volume: 6
  start-page: 80
  year: 2012
  end-page: 92
  ident: CR66
  article-title: A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
  publication-title: Fly (Austin)
  doi: 10.4161/fly.19695
– volume: 25
  start-page: 960
  year: 2011
  end-page: 967
  ident: CR31
  article-title: Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells
  publication-title: Leukemia
  doi: 10.1038/leu.2011.56
– volume: 43
  start-page: e47
  year: 2015
  ident: CR73
  article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv007
– volume: 6
  start-page: 1915
  year: 1991
  end-page: 1922
  ident: CR53
  article-title: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
  publication-title: Oncogene
– volume: 129
  start-page: 3352
  year: 2017
  end-page: 3361
  ident: CR33
  article-title: Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group
  publication-title: Blood
  doi: 10.1182/blood-2016-12-758979
– volume: 32
  start-page: 1795
  year: 2018
  end-page: 1882
  ident: CR21
  article-title: Mutant IL-7Ralpha and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia
  publication-title: Leukemia
  doi: 10.1038/s41375-017-0001-0
– volume: 33
  start-page: 314
  year: 2003
  end-page: 325
  ident: CR61
  article-title: Transgenic mice with hematopoietic and lymphoid specific expression of Cre
  publication-title: Eur. J. Immunol.
  doi: 10.1002/immu.200310005
– volume: 175
  start-page: 7325
  year: 2005
  end-page: 7331
  ident: CR28
  article-title: Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.11.7325
– volume: 7
  year: 2006
  ident: CR83
  article-title: Analysis of cell-based RNAi screens
  publication-title: Genome Biol.
  doi: 10.1186/gb-2006-7-7-r66
– volume: 98
  start-page: 1524
  year: 2001
  end-page: 1531
  ident: CR40
  article-title: Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1)
  publication-title: Blood
  doi: 10.1182/blood.V98.5.1524
– volume: 120
  start-page: 2719
  year: 2012
  end-page: 2722
  ident: CR54
  article-title: MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations
  publication-title: Blood
  doi: 10.1182/blood-2012-04-422352
– volume: 5
  start-page: e83
  year: 2008
  ident: CR36
  article-title: In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0050083
– volume: 1
  start-page: 417
  year: 2015
  end-page: 425
  ident: CR82
  article-title: The Molecular Signatures Database (MSigDB) hallmark gene set collection
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2015.12.004
– volume: 6
  year: 2015
  ident: CR35
  article-title: Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms7471
– volume: 34
  start-page: 525
  year: 2016
  end-page: 527
  ident: CR71
  article-title: Near-optimal probabilistic RNA-seq quantification
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3519
– volume: 43
  start-page: e39
  year: 2015
  ident: CR69
  article-title: CODEX: a normalization and copy number variation detection method for whole exome sequencing
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gku1363
– volume: 1
  start-page: 1657
  year: 2017
  end-page: 1671
  ident: CR58
  article-title: Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL
  publication-title: Blood Adv.
– volume: 6
  start-page: 359
  year: 2009
  end-page: 362
  ident: CR78
  article-title: Universal sample preparation method for proteome analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1322
– volume: 26
  start-page: 139
  year: 2010
  end-page: 140
  ident: CR72
  article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp616
– volume: 35
  start-page: 975
  year: 2017
  end-page: 983
  ident: CR34
  article-title: Genetic basis of acute lymphoblastic leukemia
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2016.70.7836
– volume: 126
  start-page: 1267
  year: 2016
  end-page: 1281
  ident: CR11
  article-title: LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI81468
– volume: 12
  start-page: 1212
  year: 2011
  end-page: 1220
  ident: CR29
  article-title: Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2136
– volume: 74
  start-page: 2803
  year: 2014
  end-page: 2815
  ident: CR59
  article-title: Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-2732
– volume: 125
  start-page: 3667
  year: 2015
  end-page: 3680
  ident: CR23
  article-title: Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI81158
– volume: 210
  start-page: 2823
  year: 2013
  end-page: 2832
  ident: CR57
  article-title: Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20131735
– volume: 111
  start-page: E2219
  year: 2014
  end-page: 2228
  ident: CR27
  article-title: Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1400958111
– volume: 99
  start-page: 12269
  year: 2002
  end-page: 12274
  ident: CR55
  article-title: MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.192445899
– volume: 208
  start-page: 1135
  year: 2011
  end-page: 1149
  ident: CR12
  article-title: Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101947
– volume: 129
  start-page: 177
  year: 2017
  end-page: 187
  ident: CR39
  article-title: Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2016-05-707653
– volume: 62
  start-page: 3658
  year: 2019
  end-page: 3676
  ident: CR42
  article-title: Topographical mapping of isoform-selectivity determinants for J-channel-binding inhibitors of Sphingosine Kinases 1 and 2
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b00162
– volume: 20
  start-page: 1584
  year: 2019
  end-page: 1593
  ident: CR7
  article-title: Flip the coin: IL-7 and IL-7R in health and disease
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-019-0479-x
– volume: 208
  start-page: 901
  year: 2011
  end-page: 908
  ident: CR14
  article-title: Gain-of-function mutations in interleukin-7 receptor-{alpha} (IL7R) in childhood acute lymphoblastic leukemias
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110580
– volume: 122
  start-page: 4259
  year: 2013
  end-page: 4263
  ident: CR22
  article-title: In vivo leukemogenic potential of an interleukin 7 receptor alpha chain mutant in hematopoietic stem and progenitor cells
  publication-title: Blood
  doi: 10.1182/blood-2012-08-451278
– volume: 381
  start-page: 1943
  year: 2013
  end-page: 1955
  ident: CR1
  article-title: Acute lymphoblastic leukaemia
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)62187-4
– volume: 6
  start-page: 61
  year: 1992
  end-page: 70
  ident: CR26
  article-title: Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes
  publication-title: Genes Dev.
  doi: 10.1101/gad.6.1.61
– ident: CR43
– volume: 13
  start-page: 3497
  year: 2014
  end-page: 3506
  ident: CR79
  article-title: A “proteomic ruler” for protein copy number and concentration estimation without spike-in standards
  publication-title: Mol. Cell Proteomics
  doi: 10.1074/mcp.M113.037309
– volume: 181
  start-page: 1519
  year: 1995
  end-page: 1526
  ident: CR4
  article-title: Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.181.4.1519
– ident: CR2
– volume: 25
  start-page: 2078
  year: 2009
  end-page: 2079
  ident: CR74
  article-title: The Sequence Alignment/Map format and SAMtools
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp352
– volume: 24
  start-page: 474
  year: 2018
  end-page: 483
  ident: CR38
  article-title: Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse
  publication-title: Nat. Med
  doi: 10.1038/nm.4505
– volume: 115
  start-page: 3269
  year: 2010
  end-page: 3277
  ident: CR49
  article-title: IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells
  publication-title: Blood
  doi: 10.1182/blood-2009-10-246876
– volume: 5
  start-page: 1328
  year: 2015
  end-page: 1343
  ident: CR10
  article-title: Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-15-0892
– volume: 26
  start-page: 841
  year: 2010
  end-page: 842
  ident: CR75
  article-title: BEDTools: a flexible suite of utilities for comparing genomic features
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq033
– volume: 12
  start-page: 380
  year: 2015
  end-page: 381
  ident: CR76
  article-title: MiXCR: software for comprehensive adaptive immunity profiling
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3364
– volume: 29
  start-page: 1687
  year: 2013
  end-page: 1689
  ident: CR62
  article-title: RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt203
– volume: 182
  start-page: 4255
  year: 2009
  end-page: 4266
  ident: CR9
  article-title: IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0800489
– volume: 133
  start-page: 280
  year: 2019
  end-page: 284
  ident: CR18
  article-title: PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
  publication-title: Blood
  doi: 10.1182/blood-2018-10-882142
– volume: 2016
  start-page: 561
  year: 2016
  end-page: 566
  ident: CR46
  article-title: Ph-like acute lymphoblastic leukemia
  publication-title: Hematol. Am. Soc. Hematol. Educ. Program
  doi: 10.1182/asheducation-2016.1.561
– volume: 4
  start-page: 1184
  year: 2009
  end-page: 1191
  ident: CR77
  article-title: Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2009.97
– volume: 22
  start-page: 153
  year: 2012
  end-page: 166
  ident: CR15
  article-title: Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.06.005
– volume: 211
  start-page: 701
  year: 2014
  end-page: 713
  ident: CR20
  article-title: Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20122727
– volume: 10
  start-page: e0124661
  year: 2015
  ident: CR24
  article-title: hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0124661
– ident: CR44
– volume: 13
  start-page: 731
  year: 2016
  end-page: 740
  ident: CR80
  article-title: The Perseus computational platform for comprehensive analysis of (prote)omics data
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3901
– volume: 51
  start-page: 296
  year: 2019
  end-page: 307
  ident: CR16
  article-title: PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-018-0315-5
– volume: 10
  start-page: 125
  year: 2009
  end-page: 134
  ident: CR56
  article-title: A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(08)70339-5
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  ident: CR63
  article-title: Fast and accurate short read alignment with Burrows-Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 16
  start-page: 405
  year: 2007
  end-page: 413
  ident: CR60
  article-title: Adopting the good reFLEXes when generating conditional alterations in the mouse genome
  publication-title: Transgenic Res.
  doi: 10.1007/s11248-007-9089-8
– volume: 477
  start-page: 289
  year: 2011
  end-page: 294
  ident: CR67
  article-title: Mouse genomic variation and its effect on phenotypes and gene regulation
  publication-title: Nature
  doi: 10.1038/nature10413
– volume: 18
  start-page: 694
  year: 2017
  end-page: 704
  ident: CR50
  article-title: Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3716
– volume: 134
  start-page: 2171
  year: 2019
  end-page: 2182
  ident: CR52
  article-title: IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia
  publication-title: Blood
  doi: 10.1182/blood.2019000982
– volume: 180
  start-page: 1955
  year: 1994
  end-page: 1960
  ident: CR5
  article-title: Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.180.5.1955
– volume: 21
  start-page: 289
  year: 2004
  end-page: 302
  ident: CR48
  article-title: Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.07.016
– volume: 71
  start-page: 4780
  year: 2011
  end-page: 4789
  ident: CR25
  article-title: IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3606
– volume: 43
  start-page: 932
  year: 2011
  end-page: 939
  ident: CR13
  article-title: Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
  publication-title: Nat. Genet.
  doi: 10.1038/ng.924
– volume: 4
  start-page: e7767
  year: 2009
  ident: CR64
  article-title: BFAST: an alignment tool for large scale genome resequencing
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0007767
– volume: 7
  year: 2017
  ident: CR3
  article-title: Acute lymphoblastic leukemia: a comprehensive review and 2017 update
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2017.53
– volume: 371
  start-page: 1005
  year: 2014
  end-page: 1015
  ident: CR45
  article-title: Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1403088
– volume: 114
  start-page: E4030
  year: 2017
  ident: 27197_CR51
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1702489114
– volume: 200
  start-page: 659
  year: 2004
  ident: 27197_CR41
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20040789
– volume: 5
  start-page: e83
  year: 2008
  ident: 27197_CR36
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0050083
– volume: 19
  year: 2018
  ident: 27197_CR68
  publication-title: Genome Biol.
  doi: 10.1186/s13059-018-1578-y
– volume: 99
  start-page: 12269
  year: 2002
  ident: 27197_CR55
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.192445899
– volume: 51
  start-page: 296
  year: 2019
  ident: 27197_CR16
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-018-0315-5
– volume: 33
  start-page: 1895
  year: 2019
  ident: 27197_CR19
  publication-title: Leukemia
  doi: 10.1038/s41375-019-0430-z
– volume: 71
  start-page: 4780
  year: 2011
  ident: 27197_CR25
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-3606
– volume: 6
  start-page: 359
  year: 2009
  ident: 27197_CR78
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1322
– volume: 26
  start-page: 139
  year: 2010
  ident: 27197_CR72
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp616
– volume: 25
  start-page: 2078
  year: 2009
  ident: 27197_CR74
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp352
– volume: 29
  start-page: 24
  year: 2011
  ident: 27197_CR70
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1754
– volume: 10
  start-page: e0124661
  year: 2015
  ident: 27197_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0124661
– volume: 10
  start-page: 125
  year: 2009
  ident: 27197_CR56
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(08)70339-5
– volume: 43
  start-page: 491
  year: 2011
  ident: 27197_CR65
  publication-title: Nat. Genet.
  doi: 10.1038/ng.806
– volume: 43
  start-page: 932
  year: 2011
  ident: 27197_CR13
  publication-title: Nat. Genet.
  doi: 10.1038/ng.924
– volume: 133
  start-page: 280
  year: 2019
  ident: 27197_CR18
  publication-title: Blood
  doi: 10.1182/blood-2018-10-882142
– volume: 33
  start-page: 314
  year: 2003
  ident: 27197_CR61
  publication-title: Eur. J. Immunol.
  doi: 10.1002/immu.200310005
– volume: 24
  start-page: 474
  year: 2018
  ident: 27197_CR38
  publication-title: Nat. Med
  doi: 10.1038/nm.4505
– volume: 371
  start-page: 1005
  year: 2014
  ident: 27197_CR45
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1403088
– volume: 5
  start-page: 1328
  year: 2015
  ident: 27197_CR10
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-15-0892
– volume: 1
  start-page: 1657
  year: 2017
  ident: 27197_CR58
  publication-title: Blood Adv.
  doi: 10.1182/bloodadvances.2017000547
– volume: 120
  start-page: 2843
  year: 2012
  ident: 27197_CR32
  publication-title: Blood
  doi: 10.1182/blood-2012-02-413021
– volume: 18
  start-page: 694
  year: 2017
  ident: 27197_CR50
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3716
– volume: 12
  start-page: 468
  year: 2000
  ident: 27197_CR6
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/S0952-7915(00)00122-9
– volume: 43
  start-page: e39
  year: 2015
  ident: 27197_CR69
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gku1363
– volume: 122
  start-page: 4259
  year: 2013
  ident: 27197_CR22
  publication-title: Blood
  doi: 10.1182/blood-2012-08-451278
– volume: 74
  start-page: 2803
  year: 2014
  ident: 27197_CR59
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-13-2732
– volume: 115
  start-page: 3269
  year: 2010
  ident: 27197_CR49
  publication-title: Blood
  doi: 10.1182/blood-2009-10-246876
– volume: 62
  start-page: 3658
  year: 2019
  ident: 27197_CR42
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b00162
– volume: 134
  start-page: 2171
  year: 2019
  ident: 27197_CR52
  publication-title: Blood
  doi: 10.1182/blood.2019000982
– volume: 182
  start-page: 4255
  year: 2009
  ident: 27197_CR9
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0800489
– volume: 16
  start-page: 405
  year: 2007
  ident: 27197_CR60
  publication-title: Transgenic Res.
  doi: 10.1007/s11248-007-9089-8
– volume: 6
  year: 2015
  ident: 27197_CR35
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms7471
– volume: 7
  year: 2017
  ident: 27197_CR3
  publication-title: Blood Cancer J.
  doi: 10.1038/bcj.2017.53
– volume: 12
  start-page: 1212
  year: 2011
  ident: 27197_CR29
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2136
– ident: 27197_CR43
  doi: 10.1038/s41375-021-01326-x
– volume: 21
  start-page: 289
  year: 2004
  ident: 27197_CR48
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.07.016
– volume: 115
  start-page: E11711
  year: 2018
  ident: 27197_CR17
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1814397115
– volume: 6
  start-page: 1915
  year: 1991
  ident: 27197_CR53
  publication-title: Oncogene
– volume: 181
  start-page: 1519
  year: 1995
  ident: 27197_CR4
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.181.4.1519
– volume: 32
  start-page: 1795
  year: 2018
  ident: 27197_CR21
  publication-title: Leukemia
  doi: 10.1038/s41375-017-0001-0
– volume: 381
  start-page: 1943
  year: 2013
  ident: 27197_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)62187-4
– volume: 120
  start-page: 2719
  year: 2012
  ident: 27197_CR54
  publication-title: Blood
  doi: 10.1182/blood-2012-04-422352
– volume: 25
  start-page: 960
  year: 2011
  ident: 27197_CR31
  publication-title: Leukemia
  doi: 10.1038/leu.2011.56
– volume: 29
  start-page: 1687
  year: 2013
  ident: 27197_CR62
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt203
– volume: 34
  start-page: 525
  year: 2016
  ident: 27197_CR71
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3519
– volume: 14
  start-page: 69
  year: 2014
  ident: 27197_CR8
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3570
– volume: 129
  start-page: 177
  year: 2017
  ident: 27197_CR39
  publication-title: Blood
  doi: 10.1182/blood-2016-05-707653
– volume: 111
  start-page: E2219
  year: 2014
  ident: 27197_CR27
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1400958111
– volume: 12
  start-page: 380
  year: 2015
  ident: 27197_CR76
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3364
– volume: 180
  start-page: 1955
  year: 1994
  ident: 27197_CR5
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.180.5.1955
– volume: 208
  start-page: 1135
  year: 2011
  ident: 27197_CR12
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20101947
– volume: 25
  start-page: 1754
  year: 2009
  ident: 27197_CR63
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 125
  start-page: 3667
  year: 2015
  ident: 27197_CR23
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI81158
– volume: 7
  year: 2006
  ident: 27197_CR83
  publication-title: Genome Biol.
  doi: 10.1186/gb-2006-7-7-r66
– ident: 27197_CR44
  doi: 10.1182/blood.2019000553
– volume: 477
  start-page: 289
  year: 2011
  ident: 27197_CR67
  publication-title: Nature
  doi: 10.1038/nature10413
– volume: 175
  start-page: 7325
  year: 2005
  ident: 27197_CR28
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.11.7325
– volume: 13
  start-page: 3497
  year: 2014
  ident: 27197_CR79
  publication-title: Mol. Cell Proteomics
  doi: 10.1074/mcp.M113.037309
– volume: 35
  start-page: 975
  year: 2017
  ident: 27197_CR34
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2016.70.7836
– volume: 19
  start-page: 206
  year: 2011
  ident: 27197_CR37
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.11.014
– volume: 13
  start-page: 731
  year: 2016
  ident: 27197_CR80
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3901
– volume: 211
  start-page: 701
  year: 2014
  ident: 27197_CR20
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20122727
– volume: 4
  start-page: 1184
  year: 2009
  ident: 27197_CR77
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2009.97
– volume: 126
  start-page: 1267
  year: 2016
  ident: 27197_CR11
  publication-title: J. Clin. Invest
  doi: 10.1172/JCI81468
– volume: 1
  start-page: 417
  year: 2015
  ident: 27197_CR82
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2015.12.004
– volume: 210
  start-page: 2823
  year: 2013
  ident: 27197_CR57
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20131735
– volume: 20
  start-page: 1584
  year: 2019
  ident: 27197_CR7
  publication-title: Nat. Immunol.
  doi: 10.1038/s41590-019-0479-x
– volume: 98
  start-page: 1524
  year: 2001
  ident: 27197_CR40
  publication-title: Blood
  doi: 10.1182/blood.V98.5.1524
– volume: 100
  start-page: 15113
  year: 2003
  ident: 27197_CR30
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.2436348100
– volume: 102
  start-page: 15545
  year: 2005
  ident: 27197_CR81
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0506580102
– volume: 104
  start-page: 1396
  year: 2019
  ident: 27197_CR47
  publication-title: Haematologica
  doi: 10.3324/haematol.2018.204974
– volume: 22
  start-page: 153
  year: 2012
  ident: 27197_CR15
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.06.005
– volume: 6
  start-page: 61
  year: 1992
  ident: 27197_CR26
  publication-title: Genes Dev.
  doi: 10.1101/gad.6.1.61
– volume: 43
  start-page: e47
  year: 2015
  ident: 27197_CR73
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv007
– volume: 26
  start-page: 841
  year: 2010
  ident: 27197_CR75
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq033
– volume: 6
  start-page: 80
  year: 2012
  ident: 27197_CR66
  publication-title: Fly (Austin)
  doi: 10.4161/fly.19695
– volume: 129
  start-page: 3352
  year: 2017
  ident: 27197_CR33
  publication-title: Blood
  doi: 10.1182/blood-2016-12-758979
– volume: 4
  start-page: e7767
  year: 2009
  ident: 27197_CR64
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0007767
– volume: 2016
  start-page: 561
  year: 2016
  ident: 27197_CR46
  publication-title: Hematol. Am. Soc. Hematol. Educ. Program
  doi: 10.1182/asheducation-2016.1.561
– volume: 208
  start-page: 901
  year: 2011
  ident: 27197_CR14
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110580
– ident: 27197_CR2
  doi: 10.1001/jamaoncol.2019.5582
SSID ssj0000391844
Score 2.5435586
Snippet Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function...
Interleukin-7 receptor α (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function...
Abstract Interleukin-7 receptor α (encoded by IL7R ) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R...
Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a...
SourceID doaj
pubmedcentral
hal
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7268
SubjectTerms 1-Phosphatidylinositol 3-kinase
13/31
13/95
38
38/77
38/91
42/44
45
631/67/1990/283/2125
631/67/395
631/67/70
64/110
692/4017
692/4028/67/1990/283/2125
82/58
Acute lymphoblastic leukemia
Animal models
Animals
Antineoplastic Agents - pharmacology
Cell Line, Tumor
Cell Survival - genetics
Cell viability
Cytokines
Gain of Function Mutation
Heterozygote
Homozygote
Humanities and Social Sciences
Humans
Interleukin 7
Interleukin 7 receptors
Interleukin-7 Receptor alpha Subunit - genetics
Interleukin-7 Receptor alpha Subunit - metabolism
Kinases
Leukemia
Leukemogenesis
Life Sciences
Lymphatic leukemia
Lymphocytes B
Malignancy
Mice
multidisciplinary
Mutants
Mutation
Myc protein
Pax5 protein
Penetrance
Precancerous Conditions - genetics
Precancerous Conditions - pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology
Precursor Cells, B-Lymphoid - pathology
Precursors
Proto-Oncogene Proteins p21(ras) - genetics
Receptors
Science
Science (multidisciplinary)
Signal Transduction - drug effects
Signaling
Stat5 protein
Subgroups
Suppressors
TOR protein
Transcription
Tumors
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSF9yNQUEDcwGqcOLF9Qi2i6gFVPYDUmxXHNk3ZJstmU6k_iz_Cb2LGyaYKFb1w2IszG8eZ8fibR2YIeWcsT6tEKCqUMpTbVFGTyYQy4VVSSS8yZ0KzCXF4KI-P1dHocOvGtMqNTgyK2rYV-sh3AHcrWWC9uo_LnxS7RmF0dWyhcZPcwioJWUjdO5p8LFj9XHI-fiuTZHKn40EzYF5CKpgSNJ-dR6FsP5wyJ5gUeRVxXk2c_Ct6Gg6l_fv_u5wH5N4IR-PdQX4ekhuueUTuDA0qLx6T0-AwXLj-R91QEYN2dEsw0uPfv-Kzfj36EWP8NmLw7MbAqLjGfCSAsPFyhc78Duj3KAYIgLCH4cUFSFBrALbDpDHe3J3V5RPybf_z108HdOzOQCsASWtqjVe2LMEgk75waZEDkgPjr0xl5ZURJQdgaRMjEYB6wDkALJTwiYdfYVmVZE_JVtM27jmJjRXOp6bKlGHcW2lyBZagd94KI6R1EWEbHulqLF2OHTQWOoTQM6kHvmrgqw581XlE3k__WQ6FO66l3kPWT5RYdDsMtKvvetzDWmausIUKEBRwbiFzDqYJEy4tPbdCROQtCM7sHge7XzSOYfwVLdlzFpHtjUDoUV10-lIaIvJmugwbHZlTNq7tkYZhbTSYOSLPBjGcpsq4QrscliFmAjp7lvmVpj4JxcSxvmGueEQ-bET58rH-_b5eXL-Kl-RuinuMpZTxbbK1XvXuFbldna_rbvU6bNI_FeNDew
  priority: 102
  providerName: ProQuest
Title Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia
URI https://link.springer.com/article/10.1038/s41467-021-27197-5
https://www.ncbi.nlm.nih.gov/pubmed/34907175
https://www.proquest.com/docview/2609863423
https://www.proquest.com/docview/2610412340
https://hal.science/hal-03854013
https://pubmed.ncbi.nlm.nih.gov/PMC8671594
https://doaj.org/article/83e6d6932423405685472917e2af4d77
Volume 12
WOSCitedRecordID wos000730391400016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center)
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Advanced Technologies & Aerospace Database
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: P5Z
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/hightechjournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: M7P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: 7X7
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: BENPR
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2041-1723
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000391844
  issn: 2041-1723
  databaseCode: PIMPY
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BAYkL4lkCZRUQN7CahxPbxy5qVSRYRQikwsWKY1td2GZX-6jUn8Uf4Tcx42SXLhVw4bA52LOxMzO2vxmPxwAvjeVZkwjFhFKGcZspZnKZsFR4lTTSi9yZcNmEGI3kyYmqLl31RTFhXXrgjnH7MnelLVVY9xFclLLgiAdT4bLacyvCOXJEPZeMqTAH5wpNF96fkklyub_gYU6giIRMpEqwYmslCgn7cX05pXDIq1jzasjkb_umYTk6ugt3ehwZH3T9vwfXXHsfbnU3S148gK_B0zdxq2_jlokYpzU3Q-s6_vE9PlstewdgTIcaOpdsjByOxxRIhNgzns3JC79A-iEjzz4SrrB4coGinxrE29hoTC93Z-P6IXw6Ovz45pj11yqwBtHNklnjla1rtKSkL11WFgjB0GqrM9l4ZUTNERHaxEhCjh4BCiICJXzi8VfatEnyR7DTTlv3GGJjhfOZaXJlUu6tNIVCE847b4UR0roI0jWLddPnHKerLyY67H3nUndi0SgWHcSiiwhebf4z6zJu_JV6SJLbUFK27FCAOqR7HdL_0qEIXqDct95xfPBOUxltnJIJep5GsLdWC92P84VGa1DJkrIoRvB8U40jlIRTt266IpqUkpphyxHsdlq0aSrnigxq_AyxpV9bfdmuacenIQs4JSYsFI_g9VoTf3Xrz_x68j_49RRuZzSQ0oylfA92lvOVewY3m_PleDEfwHVxIsJTDuDG8HBUfRiE0TmgwNoKn1XxBWuqt--rzz8Bl5E6bQ
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKAcGF9yNQICA4gdU8nNg-INQC1VZdqh6K1JsbxzZd2CbLPor2TyHxR_hNzDjJVktFbz1wyMVx7Dj55unxDCEvtWFJGXFJuZSaMpNIqlMR0Zg7GZXC8dRqX2yC7-6KgwO5t0J-dmdhMKyy44meUZu6RB_5OujdUuSYr-7d6DvFqlG4u9qV0GhgsWPnP8Bkm7zd_gD_91WSbH3cf9-jbVUBWoJwn1KjnTRFAYaEcLlN8gw0EDBaikSUTmpeMFCITKQFKk4O5DMIRMld5ODKTVxGKYx7iVwGNSIRPlRwb-HTwWzrgrH2bE6UivUJ85wI4yASHktOsyX558sEgFQ7wiDMsxru2UDNv3ZrvRDcuvm_fb5b5EarbocbDX3cJiu2ukOuNgU453fJV-8QHdrZt0FFeQjc346m9Tj8_Ss8nk1bP2mIZz8az3UIQAwHGG8FKno4GuNmxQT6b1LcAIGOM2gezoFCag1mCUwa4uD2eFDcI58vZKH3yWpVV_YhCbXh1iW6TKWOmTNCZxIsXWed4ZoLYwMSd5hQZZuaHSuEDJUPEUiFanCkAEfK40hlAXm9eGbUJCY5t_cmQm3RE5OK-4Z6_EW1PEqJ1OYml17FBj0-FxkD0yvmNikcM5wH5AUAdWmM3kZfYRvuL6OlfhIHZK0DoGrZ4USdoi8gzxe3gZHhzykqW8-wT4y532DmgDxoYL-YKmUS_Q6wDL5EEEvvsnynGhz5ZOmYvzGTLCBvOtI5fa1_f69H56_iGbnW2__UV_3t3Z3H5HqC9B0nNGZrZHU6ntkn5Ep5Mh1Mxk89gwjJ4UWT1B_9uZ6k
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3LbtQw0CrlIS68H4ECAcEJrM3Die0DQi2latVqtQeQejNxbNOFbbLso2g_iysfwTcx4yRbLRW99cAhF2dix8m8ZzxDyEttWFJGXFIupabMJJLqVEQ05k5GpXA8tdo3m-D9vjg8lIM18qs7C4NplR1P9Iza1CX6yHugd0uRY726nmvTIgbbO-_G3yl2kMJIa9dOo0GRfbv4Aebb9O3eNvzrV0my8-Hj-13adhigJQj6GTXaSVMUYFQIl9skz0AbAQOmSETppOYFA-XIRFqgEuVAVoNwlNxFDq7cxGWUwryXyGWORct92uBg6d_ByuuCsfacTpSK3pR5roQ5EQmPJafZiiz0LQNAwh1hQuZZbfds0uZfkVsvEHdu_s-f8ha50arh4WZDN7fJmq3ukKtNY87FXfLVO0pHdv5tWFEeglSw41k9CX__DI_ns9Z_GuKZkMajHQKChkPMwwLVPRxPMIgxBfgtioERAJzD8GgBlFNrMFdg0RAnt8fD4h75dCEbvU_Wq7qyD0moDbcu0WUqdcycETqTYAE76wzXXBgbkLjDD1W2Jduxc8hI-dSBVKgGpxTglPI4pbKAvF4-M24KlpwLvYVot4TEYuN-oJ58US3vUiK1ucmlV71Bv89FxsAki7lNCscM5wF5AUi7Msfu5oHCMYw7owV_Egdko0NG1bLJqTrFxIA8X94GBoc_p6hsPUeYGGvCwcoBedCQwHKplEn0R8A2-ApxrLzL6p1qeOSLqGNdx0yygLzpyOj0tf79vR6dv4tn5BpQkjrY6-8_JtcTJPU4oTHbIOuzydw-IVfKk9lwOnnqeUVIPl80Rf0BASCnYQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin-7+receptor+%CE%B1+mutational+activation+can+initiate+precursor+B-cell+acute+lymphoblastic+leukemia&rft.jtitle=Nature+communications&rft.au=Almeida%2C+Afonso+R+M&rft.au=Neto%2C+Jo%C3%A3o+L&rft.au=Cachucho%2C+Ana&rft.au=Euz%C3%A9bio%2C+Mayara&rft.date=2021-12-14&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=12&rft.issue=1&rft.spage=7268&rft_id=info:doi/10.1038%2Fs41467-021-27197-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon